VACCINE AGAINST HERPES SIMPLEX VIRUS TYPE 2: COMPOSITIONS AND METHODS FOR TRIGGERING IMMUNE RESPONSE Russian patent published in 2016 - IPC A61K39/245 A61P31/22 

FIELD: medicine; immunology.

SUBSTANCE: group of inventions relates to medicine, specifically to immunology, and can be used to obtain a vaccine against herpes simplex virus (HSV). Drug comprises a pharmaceutically acceptable carrier and a polypeptide comprising amino acid sequence of SEQ ID NO. 2 or amino acid sequence SEQ ID NO. 2, wherein 1-20 amino acids are absent from N-terminus, C-terminus or both. Group of inventions also relates to use of isolated polypeptides for preparing a medicament for treating a patient from herpes simplex virus infection.

EFFECT: use of this group of inventions enables to use isolated polypeptides represented by SEQ ID NO 2 separately or in a combination with SEQ ID NO 4 and SEQ ID NO 5 as an effective vaccine.

138 cl, 16 tbl, 6 dwg